D
grade
Anti-osteoporotic Pharmacotherapy and Muscle Outcomes in Osteosarcopenia: a Source-Verified Translational Evidence Map.
Abaloparatide (Tymlos) · Calcified tissue international · 2026 · Review
Anti-osteoporotic drugs like denosumab and abaloparatide show limited evidence for improving muscle outcomes in osteosarcopenia, despite their benefits for bone health.
Not reported in abstract.